+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Middle East & Africa Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Middle East & Africa Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 181 Pages
  • Middle East, Africa
From
Semaglutide Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Semaglutide Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 81 Pages
  • Global
From
SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • September 2025
  • 87 Pages
  • Global
From
Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • September 2025
  • 142 Pages
  • Global
From
DPP-4 Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

DPP-4 Inhibitor Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • August 2025
  • 98 Pages
  • Global
From
Antidiabetics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Antidiabetics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 90 Pages
  • Global
From
Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • April 2025
  • 90 Pages
  • Global
From
GLP-1 Agonists Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology - Product Thumbnail Image

GLP-1 Agonists Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology

  • Report
  • March 2025
  • 83 Pages
  • Global
From
GCC Glp 1 Agonists Weight Loss Drugs Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Thumbnail Image

GCC Glp 1 Agonists Weight Loss Drugs Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • October 2025
  • 86 Pages
  • Middle East
From
Japan Auto-Injectors for Glp-1 Receptor Agonists Market Outlook 2038 - Product Thumbnail Image

Japan Auto-Injectors for Glp-1 Receptor Agonists Market Outlook 2038

  • Report
  • July 2025
  • 90 Pages
  • Japan
From
Middle East and Africa Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 81 Pages
  • Africa, Middle East
From
Asia-Pacific Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 97 Pages
  • Asia Pacific
From
Europe Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

Europe Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 100 Pages
  • Europe
From
North America Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

North America Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 89 Pages
  • North America
From
Diabetes Drug Market Overview, 2025-30 - Product Thumbnail Image

Diabetes Drug Market Overview, 2025-30

  • Report
  • June 2025
  • 109 Pages
  • Global
From
South America Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

South America Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 81 Pages
From
Diabetes Drug Market Outlook, 2030 - Product Thumbnail Image

Diabetes Drug Market Outlook, 2030

  • Report
  • June 2025
  • 198 Pages
  • Global
From
Middle East Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Thumbnail Image

Middle East Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • March 2025
  • 260 Pages
  • Middle East
From
Africa Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Thumbnail Image

Africa Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • March 2025
  • 260 Pages
  • Africa
From
Latin America Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update - Product Thumbnail Image

Latin America Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update

  • Report
  • March 2025
  • 210 Pages
  • Latin America
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more